mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.08 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |